An article in the June, 2022, issue of the European Respiratory Review explores technological advancements in the development of electronic monitoring of inhaler devices in order to monitor use and provide feedback on inhaler technique for some devices. The authors explain, “Most electronic monitoring devices (EMDs) are paired with a smartphone application, allowing patients to set reminders and display both preventer and reliever use over time. This allows identification of intentional and unintentional ICS non-adherence as well as frequency of SABA use. This information assists clinicians in distinguishing difficult-to-control from severe asthma.” The researchers also note that additional evidence is required to assess the impact of these electronic devices on clinical outcomes.
To read the full abstract, click here.